Alte Biosciences Announces License Deal with Duke University

CARY, N.C.--(BUSINESS WIRE)--Alte Biosciences Inc., a drug development company located in Cary, NC, announces that it has secured exclusive rights to intellectual property developed at the Duke University Medical Center, Durham NC, for novel therapeutics targeting late-onset depression and related disorders. The licensed technology is a patent based on findings by Dr. Ranga Krishnan, M.D., M.B.B.S., Ch.B. on the relationship between cerebrovascular disease and the onset of depression in elderly individuals, a disease called vascular depression. Dr. Krishnan is Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center, and a leading clinician in treating refractory depression and anxiety disorders.